(Q52631091)

4 May 2018

title

Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus. (English)

1 reference

4 May 2018

methicillin-resistant Staphylococcus aureus

main subject

0 references

Staphylococcus aureus

1 reference

Ruoyu Mao

1

1 reference

4 May 2018

Da Teng

2

1 reference

4 May 2018

Xiumin Wang

3

1 reference

4 May 2018

Di Xi

4

1 reference

4 May 2018

Yong Zhang

5

1 reference

4 May 2018

Xiaoyuan Hu

6

1 reference

4 May 2018

Yalin Yang

7

1 reference

4 May 2018

Jianhua Wang

8

1 reference

4 May 2018

language of work or name

English

0 references

publication date

25 October 2012

1 reference

4 May 2018

Applied Microbiology and Biotechnology

published in

1 reference

4 May 2018

volume

97

1 reference

4 May 2018

issue

9

1 reference

4 May 2018

page(s)

3991-4002

1 reference

4 May 2018

Innate immunity and the normal microflora

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

The changing epidemiology of Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Enterococcal peptide sex pheromones: synthesis and control of biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Plectasin has antibacterial activity and no affect on cell viability or IL-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Genotypes and toxin gene profiles of Staphylococcus aureus clinical isolates from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Methicillin-resistant Staphylococcus aureus ocular infection: a 10-year hospital-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Cell density control of staphylococcal virulence mediated by an octapeptide pheromone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

The biology of mating in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Recurrent infections and immune evasion strategies of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Antibacterial peptides for therapeutic use: obstacles and realistic outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

The crisis in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Methicillin-resistant Staphylococcus aureus infection is associated with increased mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Experimental evolution of resistance to an antimicrobial peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Expression of the recombinant antibacterial peptide sarcotoxin IA in Escherichia coli cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Expression of antimicrobial peptide LH multimers in Escherichia coli C43(DE3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

High-level expression and novel antifungal activity of mouse beta defensin-1 mature peptide in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Targeted anti bacterial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Mechanisms of antimicrobial peptide action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4508-Z

10.1007/S00253-012-4508-Z

21 January 2018

Identifiers

DOI

1 reference

4 May 2018

release_road23butrbyfn4vyd7aorjnum

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/road23butrbyfn4vyd7aorjnum

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 May 2018